vx has been researched along with echothiophate iodide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eldefrawi, AT; Eldefrawi, ME; Silveira, CL | 1 |
| Broomfield, CA; Lockridge, O; Millard, CB | 1 |
| Barak, D; Pittel, Z; Segall, Y | 1 |
| Carletti, E; Lockridge, O; Masson, P; Nachon, F; Nicolet, Y; Schopfer, LM; Wandhammer, M | 1 |
4 other study(ies) available for vx and echothiophate iodide
| Article | Year |
|---|---|
Putative M2 muscarinic receptors of rat heart have high affinity for organophosphorus anticholinesterases.
Topics: Animals; Cholinesterase Inhibitors; Dioxolanes; Dose-Response Relationship, Drug; Echothiophate Iodide; Insecticides; Male; Myocardium; Organophosphates; Organophosphorus Compounds; Organothiophosphorus Compounds; Paraoxon; Parasympathomimetics; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Sarin; Soman; Tritium | 1990 |
Protein engineering of a human enzyme that hydrolyzes V and G nerve agents: design, construction and characterization.
Topics: Animals; Benzoylcholine; Binding Sites; Butyrylcholinesterase; Butyrylthiocholine; Cephamycins; Chemical Warfare Agents; Cholinesterase Inhibitors; Drug Design; Echothiophate Iodide; Humans; Hydrolysis; Inactivation, Metabolic; Kinetics; Mutagenesis, Site-Directed; Organophosphates; Organothiophosphorus Compounds; Protein Engineering; Sarin; Soman; Torpedo | 1999 |
Function-specific blockage of M(1) and M(3) muscarinic acetylcholine receptors by VX and echothiophate.
Topics: Animals; Atropine; CHO Cells; Cholinesterase Inhibitors; Colforsin; Cricetinae; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Echothiophate Iodide; Muscarinic Agonists; Muscarinic Antagonists; N-Methylscopolamine; Organothiophosphorus Compounds; Oxotremorine; Phosphatidylinositols; Protein Binding; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Transfection; Tritium | 2006 |
X-ray crystallographic snapshots of reaction intermediates in the G117H mutant of human butyrylcholinesterase, a nerve agent target engineered into a catalytic bioscavenger.
Topics: Amino Acid Substitution; Butyrylcholinesterase; Catalytic Domain; Crystallography, X-Ray; Echothiophate Iodide; Gene Expression Regulation, Enzymologic; Humans; Models, Molecular; Molecular Structure; Mutagenesis, Site-Directed; Organophosphorus Compounds; Organothiophosphorus Compounds; Protein Engineering; Receptors, Fc | 2011 |